Diabetes
Chronic Kidney Disease in Adults: Age and Comorbid
Chronic Kidney Disease in Adults: Age and Comorbidity Associations

Risk of chronic kidney disease increases with age and comorbidities such as hypertension, diabetes, and cardiovascular disease, highlighting the importance of early detection and targeted risk factor modification in primary and secondary prevention efforts.

November 2021

Does COVID-19 induce diabetes?
Does COVID-19 induce diabetes?

COVID-19 infection, like other infections, can cause hyperglycemia in people without known diabetes,

November 2021

Diabetes, Kidney Function, and Pregnancy Preventio
Diabetes, Kidney Function, and Pregnancy Prevention

Gestational diabetes mellitus, diagnosed in the second or third trimester of pregnancy, presents challenges in managing blood glucose levels and preventing adverse maternal and fetal outcomes, underscoring the importance of early detection and targeted interventions in at-risk populations.

October 2021

Fatty Liver and Type 2 Diabetes: Remission Associa
Fatty Liver and Type 2 Diabetes: Remission Associations

Inverse association between fatty liver at baseline and type 2 diabetes remission over a 2-year follow-up period is observed, suggesting potential implications for understanding metabolic interactions and informing therapeutic interventions in diabetic patients with hepatic steatosis.

October 2021

Cardiovascular Risk in Gestational Diabetes: Long-
Cardiovascular Risk in Gestational Diabetes: Long-Term Implications

Women with gestational diabetes mellitus have a significantly increased risk of calcification of the cardiac arteries, even after maintaining normal blood glucose levels post-pregnancy, highlighting the importance of cardiovascular risk assessment and preventive measures in this population.

October 2021

Clinical Pharmacist Interventions in Type 2 Diabet
Clinical Pharmacist Interventions in Type 2 Diabetes Management: Systematic Review

Systematic review evaluates the impact of clinical pharmacist interventions in type 2 diabetes management, highlighting their role in optimizing medication therapy and improving clinical outcomes for diabetic patients.

May 2021

ASA, Clopidogrel, and Prasugrel in Type 2 Diabetes
ASA, Clopidogrel, and Prasugrel in Type 2 Diabetes: Thrombotic Marker Effects

A double-blind randomized controlled trial evaluates the effects of ASA, clopidogrel, and prasugrel on thrombotic markers and microRNA levels in patients with type 2 diabetes, providing insights into antiplatelet therapy efficacy and safety profiles in diabetic populations.

December 2020

Practical Recommendations for Diabetes Management
Practical Recommendations for Diabetes Management during COVID-19: Expert Consensus

An international panel of experts provides practical guidance and recommendations for managing diabetes during the COVID-19 pandemic, addressing unique challenges and considerations to optimize diabetes care and minimize associated risks in affected individuals.

November 2020

Awareness of Cardiovascular Risk Low Among Diabeti
Awareness of Cardiovascular Risk Low Among Diabetics

A survey of over 2,000 diabetics in the United States reveals that the majority are unaware of the increased risk of cardiovascular disease associated with diabetes. This highlights the need for improved education and awareness campaigns targeting diabetic patients.

November 2002

Genetic Region Implicated in Obesity and Diabetes
Genetic Region Implicated in Obesity and Diabetes

A new study published in Diabetes identifies a region on chromosome 3 containing genes associated with obesity and diabetes. This discovery provides valuable insights into the genetic factors contributing to these metabolic disorders.

October 2002